Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Cardiovasc Diabetol 24:166
Plant J 52 (5): 973-86
Experto Universitario en Competencias docentes y digitales en Ciencias de la Salud
Our lead clinical programs drug candidate, VK2735, is being developed in both oral and subcutaneous formulations for the potential treatment of various metabolic disorders such as obesity
Diabetes Care 30:12121218 Grygiel-Grniak B (2014) Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications a review
US$ 21.90
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
US$ 23.23
US$ 27.63
US$ 29.97
US$ 25.60
